deltatrials
Completed EARLY_PHASE1 INTERVENTIONAL 1-arm NCT03039413

Copper Cu-64 TP3805 PET/CT in Imaging Patients With Urothelial Cancer Undergoing Surgery or Biopsy

Targeting a Genomic Biomarker for PET Imaging and Staging of Urothelial Cancer: A Preliminary Evaluation

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Conditions Bladder Urothelial Carcinoma Urothelial Carcinoma
Interventions Computed Tomography Copper Cu 64 TP3805 Positron Emission Tomography
Updated 16 times since 2017 Last updated: Aug 20, 2025 Started: Sep 28, 2016 Primary completion: May 21, 2019 Completion: Jul 19, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03039413, this EARLY_PHASE1 trial focuses on Bladder Urothelial Carcinoma and Urothelial Carcinoma and remains completed. Sponsored by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, it has been updated 16 times since 2016, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Feb 2017 – ~Oct 2017 · 8 months · monthly snapshot~Oct 2017 – ~Jun 2018 · 8 months · monthly snapshot~Jun 2018 – ~Dec 2018 · 6 months · monthly snapshot~Dec 2018 – ~Jan 2020 · 13 months · monthly snapshot~Jan 2020 – ~Jan 2021 · 12 months · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Sep 2021 · 7 months · monthly snapshot~Sep 2021 – ~Oct 2021 · 30 days · monthly snapshot~Oct 2021 – ~Jan 2023 · 15 months · monthly snapshot~Jan 2023 – ~Jul 2023 · 6 months · monthly snapshot~Jul 2023 – ~Jul 2024 · 12 months · monthly snapshot~Jul 2024 – ~Aug 2024 · 31 days · monthly snapshot~Aug 2024 – ~Sep 2024 · 31 days · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – ~Feb 2026 · 5 months · monthly snapshot~Feb 2026 – present · 5 months · monthly snapshot

Change History

16 versions recorded

  1. Feb 2026 — Present [monthly]

    Completed EARLY_PHASE1

  2. Sep 2025 — Feb 2026 [monthly]

    Completed EARLY_PHASE1

  3. Sep 2024 — Sep 2025 [monthly]

    Completed EARLY_PHASE1

  4. Aug 2024 — Sep 2024 [monthly]

    Completed EARLY_PHASE1

    Status: Active Not Recruiting → Completed

  5. Jul 2024 — Aug 2024 [monthly]

    Active Not Recruiting EARLY_PHASE1

▶ Show 11 earlier versions

  1. Jul 2023 — Jul 2024 [monthly]

    Active Not Recruiting EARLY_PHASE1

  2. Jan 2023 — Jul 2023 [monthly]

    Active Not Recruiting EARLY_PHASE1

  3. Oct 2021 — Jan 2023 [monthly]

    Active Not Recruiting EARLY_PHASE1

  4. Sep 2021 — Oct 2021 [monthly]

    Active Not Recruiting EARLY_PHASE1

  5. Feb 2021 — Sep 2021 [monthly]

    Active Not Recruiting EARLY_PHASE1

  6. Jan 2021 — Feb 2021 [monthly]

    Active Not Recruiting EARLY_PHASE1

  7. Jan 2020 — Jan 2021 [monthly]

    Active Not Recruiting EARLY_PHASE1

    Status: Recruiting → Active Not Recruiting

  8. Dec 2018 — Jan 2020 [monthly]

    Recruiting EARLY_PHASE1

  9. Jun 2018 — Dec 2018 [monthly]

    Recruiting EARLY_PHASE1

  10. Oct 2017 — Jun 2018 [monthly]

    Recruiting EARLY_PHASE1

  11. Feb 2017 — Oct 2017 [monthly]

    Recruiting EARLY_PHASE1

    First recorded

Sep 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Data source: Thomas Jefferson University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations